Patient characteristics for adult HCT respondents subdivided by allogeneic vs autologous transplant
| Characteristic . | All respondents N = 1861 . | Allogeneic HCT (any) N = 1220 . | Autologous HCT (only) N = 641 . |
|---|---|---|---|
| Female sex, n (%) | 888 (47.7) | 584 (47.9) | 304 (47.4) |
| Race/ethnicity, n (%) | |||
| White | 1660 (89.2) | 1103 (90.4) | 557 (86.9) |
| Non-White | 116 (6.2) | 79 (6.5) | 37 (5.8) |
| Unknown or unreported | 85 (4.6) | 38 (3.1) | 47 (7.3) |
| Current age, y, median (IQR) | 64.2 (56.8, 70.5) | 63.1 (55.3, 69.2) | 66.4 (59.8, 72.0) |
| <50, n (%) | 221 (11.9) | 170 (13.9) | 51 (8.0) |
| 50-59, n (%) | 408 (21.9) | 298 (24.4) | 110 (17.2) |
| 60-69, n (%) | 736 (39.6) | 479 (39.3) | 257 (40.1) |
| ≥70, n (%) | 496 (26.6) | 273 (22.4) | 223 (34.8) |
| Underlying diagnosis, n (%) | |||
| Acute leukemia | 418 (22.5) | 407 (33.5) | 11 (1.7) |
| Chronic leukemia | 363 (19.5) | 361 (29.7) | 2 (0.3) |
| Lymphoma | 409 (22.0) | 104 (8.6) | 305 (48.0) |
| Multiple myeloma | 320 (17.2) | 63 (5.2) | 257 (40.5) |
| Myelodysplastic syndrome | 80 (4.3) | 80 (6.6) | 0 |
| Solid tumor | 31 (1.7) | 3 (0.3) | 28 (4.4) |
| Aplastic anemia | 45 (2.4) | 45 (3.7) | 0 |
| Other diagnosis | 195 (10.5) | 153 (12.5) | 32 (5.0) |
| Number of transplants, n (%) | |||
| 1 | 1668 (89.6) | 1052 (86.2) | 616 (96.1) |
| >1 | 193 (10.4) | 168 (13.8) | 25 (3.9) |
| Time since transplant, y, median (IQR) | 12.0 (6.0, 21.0) | 15.0 (7.0, 22.7) | 8.1 (4.3, 15.0) |
| Myeloablative transplant, n (%) | |||
| No | 154 (8.3) | 154 (12.6) | 0 |
| Yes | 1707 (91.7) | 1066 (87.4) | 641 (100) |
| TBI (cumulative), n (%) | |||
| None | 970 (52.1) | 439 (36.0) | 531 (82.8) |
| Any | 891 (47.9) | 781 (64.0) | 110 (17.2) |
| Diagnosis of chronic GVHD, n (%) | |||
| Never | 1049 (56.4) | 408 (33.4) | 641 (100) |
| Yes | 812 (43.6) | 812 (66.6) | 0 |
| Education level if age >25 y, n (%) | |||
| Less than 4-y college | 800 (43.5) | 505 (41.9) | 295 (46.6) |
| Completed college | 1039 (56.5) | 701 (58.1) | 338 (53.4) |
| History of hearing issues, n (%) | |||
| No | 1288 (69.6) | 877 (72.5) | 411 (64.2) |
| Yes | 562 (30.4) | 333 (27.5) | 229 (35.8) |
| History of stroke/seizures, n (%) | |||
| No | 1647 (90.3) | 1075 (89.8) | 572 (91.2) |
| Yes | 177 (9.7) | 122 (10.2) | 55 (8.8) |
| Characteristic . | All respondents N = 1861 . | Allogeneic HCT (any) N = 1220 . | Autologous HCT (only) N = 641 . |
|---|---|---|---|
| Female sex, n (%) | 888 (47.7) | 584 (47.9) | 304 (47.4) |
| Race/ethnicity, n (%) | |||
| White | 1660 (89.2) | 1103 (90.4) | 557 (86.9) |
| Non-White | 116 (6.2) | 79 (6.5) | 37 (5.8) |
| Unknown or unreported | 85 (4.6) | 38 (3.1) | 47 (7.3) |
| Current age, y, median (IQR) | 64.2 (56.8, 70.5) | 63.1 (55.3, 69.2) | 66.4 (59.8, 72.0) |
| <50, n (%) | 221 (11.9) | 170 (13.9) | 51 (8.0) |
| 50-59, n (%) | 408 (21.9) | 298 (24.4) | 110 (17.2) |
| 60-69, n (%) | 736 (39.6) | 479 (39.3) | 257 (40.1) |
| ≥70, n (%) | 496 (26.6) | 273 (22.4) | 223 (34.8) |
| Underlying diagnosis, n (%) | |||
| Acute leukemia | 418 (22.5) | 407 (33.5) | 11 (1.7) |
| Chronic leukemia | 363 (19.5) | 361 (29.7) | 2 (0.3) |
| Lymphoma | 409 (22.0) | 104 (8.6) | 305 (48.0) |
| Multiple myeloma | 320 (17.2) | 63 (5.2) | 257 (40.5) |
| Myelodysplastic syndrome | 80 (4.3) | 80 (6.6) | 0 |
| Solid tumor | 31 (1.7) | 3 (0.3) | 28 (4.4) |
| Aplastic anemia | 45 (2.4) | 45 (3.7) | 0 |
| Other diagnosis | 195 (10.5) | 153 (12.5) | 32 (5.0) |
| Number of transplants, n (%) | |||
| 1 | 1668 (89.6) | 1052 (86.2) | 616 (96.1) |
| >1 | 193 (10.4) | 168 (13.8) | 25 (3.9) |
| Time since transplant, y, median (IQR) | 12.0 (6.0, 21.0) | 15.0 (7.0, 22.7) | 8.1 (4.3, 15.0) |
| Myeloablative transplant, n (%) | |||
| No | 154 (8.3) | 154 (12.6) | 0 |
| Yes | 1707 (91.7) | 1066 (87.4) | 641 (100) |
| TBI (cumulative), n (%) | |||
| None | 970 (52.1) | 439 (36.0) | 531 (82.8) |
| Any | 891 (47.9) | 781 (64.0) | 110 (17.2) |
| Diagnosis of chronic GVHD, n (%) | |||
| Never | 1049 (56.4) | 408 (33.4) | 641 (100) |
| Yes | 812 (43.6) | 812 (66.6) | 0 |
| Education level if age >25 y, n (%) | |||
| Less than 4-y college | 800 (43.5) | 505 (41.9) | 295 (46.6) |
| Completed college | 1039 (56.5) | 701 (58.1) | 338 (53.4) |
| History of hearing issues, n (%) | |||
| No | 1288 (69.6) | 877 (72.5) | 411 (64.2) |
| Yes | 562 (30.4) | 333 (27.5) | 229 (35.8) |
| History of stroke/seizures, n (%) | |||
| No | 1647 (90.3) | 1075 (89.8) | 572 (91.2) |
| Yes | 177 (9.7) | 122 (10.2) | 55 (8.8) |